-
-
This study reports findings from a survey of 1,082 US physicians (62% response rate) regarding their attitudes about reporting medical errors and suggestions for ways to prevent common errors.
-
Regionalized health care systems exist for trauma and neonatal care and efforts are underway to institute similar systems for high-risk surgeries, three fields in which there is a positive relationship between the volume of cases handled and patient outcomes.
-
This study sought to determine whether the occurrence of in-hospital cardiac arrest at night and on weekends was associated with worse outcomes as compared with arrests during day/evening shifts and on weekdays.
-
In This Issue: FDA drug approval to change? Urinary incontinence in women; how metabolism of certain drugs can be predicted by genetic analysis; bowel preps may compromise renal function especially in the elderly according to a new study; FDA Actions.
-
This multicenter, randomized, double-blind, placebo-controlled trial of hydrocortisone replacement in septic shock aimed to evaluate 28-day mortality in non-responders to corticotropin stimulation.
-
Trauma surgeons at the Regional Medical Center at Memphis carried out a randomized clinical trial comparing a continuous ethanol infusion with a protocol of scheduled diazepam administration for the prevention and control of severe alcohol withdrawal syndrome (AWS) among patients admitted to their ICU following trauma.
-
It is now well established that ventilating patients with acute lung injury (ALI) and the acute respiratory distress syndrome (ARDS) using a strategy that limits alveolar distending volume and end-inspiratory static airway pressure results in improved survival, as compared to larger-volume, higher-pressure ventilation.
-
This multicenter randomized trialnicknamed the VISEP studyused a two-by-two factorial design to test two independent treatments in severe sepsis patients.
-
In this issue: Does erythropoietin worsen cancer death rates? Most hypothyroid patients can be replaced with levothyroxine alone without additional T3. Does aggressive control in type 2 diabetes save lives?
